UNIGE document Scientific Article
previous document  unige:76373  next document
add to browser collection

Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants

O'Gorman, Ruth L
Bucher, Hans U
Held, Ulrike
Koller, Brigitte M
Hagmann, Cornelia F
Published in Brain. 2015, vol. 138, no. Pt 2, p. 388-397
Abstract Despite improved survival, many preterm infants undergo subsequent neurodevelopmental impairment. To date, no neuroprotective therapies have been implemented into clinical practice. Erythropoietin, a haematopoietic cytokine used for treatment of anaemia of prematurity, has been shown to have neuroprotective and neuroregenerative effects on the brain in many experimental studies. The aim of the study was to assess the effect of recombinant human erythropoietin on the microstructural development of the cerebral white matter using tract-based spatial statistics performed at term equivalent age. A randomized, double-blind placebo-controlled, prospective multicentre study applying recombinant human erythropoietin in the first 42 h after preterm birth entitled 'Does erythropoietin improve outcome in preterm infant' was conducted in Switzerland (NCT00413946). Preterm infants were given recombinant human erythropoietin (3000 IU) or an equivalent volume of placebo (NaCl 0.9%) intravenously before 3 h of age after birth, at 12-18 h and at 36-42 h after birth. High resolution diffusion tensor imaging was obtained at 3 T in 58 preterm infants with mean (standard deviation) gestational age at birth 29.75 (1.44) weeks, and at scanning at 41.1 (2.09) weeks. Imaging was performed at a single centre. Voxel-wise statistical analysis of the fractional anisotropy data was carried out using tract-based spatial statistics to test for differences in fractional anisotropy between infants treated with recombinant human erythropoietin and placebo using a general linear model, covarying for the gestational age at birth and the corrected gestational age at the time of the scan. Preterm infants treated with recombinant human erythropoietin demonstrated increased fractional anisotropy in the genu and splenium of the corpus callosum, the anterior and posterior limbs of the internal capsule, and the corticospinal tract bilaterally. Mean fractional anisotropy was significantly higher in preterm infants treated with recombinant human erythropoietin than in those treated with placebo (P < 0.001). We conclude that early recombinant human erythropoietin administration improves white matter development in preterm infants assessed by diffusion tensor imaging and tract-based spatial statistics.
Keywords Diffusion Magnetic Resonance ImagingDouble-Blind MethodErythropoietin/therapeutic useFemaleHumansInfantInfant, NewbornInfant, PrematureMagnetic Resonance ImagingMaleNeuroprotective Agents/therapeutic useProspective StudiesPyramidal Tracts/growth & developmentRecombinant Proteins/therapeutic useSex CharacteristicsWhite Matter/drug effects/growth & development
PMID: 25534356
Full text
Article (Published version) (440 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group L'imagerie cérébrale (184)
(ISO format)
O'GORMAN, Ruth L et al. Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants. In: Brain, 2015, vol. 138, n° Pt 2, p. 388-397. doi: 10.1093/brain/awu363 https://archive-ouverte.unige.ch/unige:76373

398 hits

0 download


Deposited on : 2015-10-22

Export document
Format :
Citation style :